Table 1.
Groups | Number of cats | s.c. dosage (mean ± SD) in mg/kg | Daily oral dosage (mean ± SD) in mg/kg* | ||
---|---|---|---|---|---|
Target | Actual | Target | Actual | ||
Robenacoxib (s.c. + oral) | 101 | 2.0 | 2.0 ± 0.09 | 1.0 – 2.4 | 1.58 ± 0.41 |
Meloxicam (s.c. + placebo oral) | 46 | 0.3 | 0.3 ± 0.005 | - | - |
s.c.: subcutaneous.
*Robenacoxib and placebo tablets were administered once daily for 9 (range, 7–11) days.